Brief: China Regenerative Medicine International Announces Further Sales Of Interest By Unit
21/02/2020 15:05
Feb 21 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* UNIT TO TRANSFER REMAINING 85% OF INVESTMENT OF ITS CLASS
B
INTEREST TO XIONG QIANGEN FOR $32.9 MILLION
Source text for Eikon: ID:nHKS85ZsG4
Further company coverage: 8158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital